Jones MH, Oak SR, Andrish JT, Brophy RH, Cox CL, Dunn WR, Flanigan DC, Fleming BC, Huston LJ, Kaeding CC, Kolosky M, Kuyumcu G, Lynch TS, Magnussen RA, Matava MJ, Parker RD, Reinke EK, Scaramuzza EA, Smith MV, Winalski C, Wright RW, Zajichek A, and Spindler KP
Background: Multiple studies have shown that patients are susceptible to posttraumatic osteoarthritis (PTOA) after an anterior cruciate ligament (ACL) injury, even with ACL reconstruction (ACLR). Prospective studies using multivariable analysis to identify risk factors for PTOA are lacking., Purpose/hypothesis: This study aimed to identify baseline predictors of radiographic PTOA after ACLR at an early time point. We hypothesized that meniscal injuries and cartilage lesions would be associated with worse radiographic PTOA using the Osteoarthritis Research Society International (OARSI) atlas criteria., Study Design: Cohort study; Level of evidence, 3., Methods: A total of 421 patients who underwent ACLR returned on-site for standardized posteroanterior semiflexed knee radiography at a minimum of 2 years after surgery. The mean age was 19.8 years, with 51.3% female patients. At baseline, data on demographics, graft type, meniscal status/treatment, and cartilage status were collected. OARSI atlas criteria were used to grade all knee radiographs. Multivariable ordinal regression models identified baseline predictors of radiographic OARSI grades at follow-up., Results: Older age (odds ratio [OR], 1.06) and higher body mass index (OR, 1.05) were statistically significantly associated with a higher OARSI grade in the medial compartment. Patients who underwent meniscal repair and partial meniscectomy had statistically significantly higher OARSI grades in the medial compartment (meniscal repair OR, 1.92; meniscectomy OR, 2.11) and in the lateral compartment (meniscal repair OR, 1.96; meniscectomy OR, 2.97). Graft type, cartilage lesions, sex, and Marx activity rating scale score had no significant association with the OARSI grade., Conclusion: Older patients with a higher body mass index who have an ACL tear with a concurrent meniscal tear requiring partial meniscectomy or meniscal repair should be advised of their increased risk of developing radiographic PTOA. Alternatively, patients with an ACL tear with an articular cartilage lesion can be reassured that they are not at an increased risk of developing early radiographic knee PTOA at 2 to 3 years after ACLR., Competing Interests: One or more of the authors has declared the following potential conflict of interest or source of funding: Research reported in this publication was partially supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under award number R01AR053684 (K.P.S.) and under award number K23AR066133 (which supported a portion of M.H.J.’s professional effort). The content is solely the responsibility of the authors and does not necessarily represent official views of the National Institutes of Health. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto. One or more of the authors has declared the following potential conflict of interest or source of funding: M.H.J. is on the scientific advisory board for Samumed. R.H.B. has received educational support from Elite Orthopedics; speaking fees from Smith & Nephew; research support from Zimmer; and consulting fees from Arthrex, ISTO, and Sanofi-Aventis. C.L.C.’s relative is an employee of Smith & Nephew. W.R.D. has received consulting fees from Linvatec and hospitality payments from Wright Medical. D.C.F. is a paid consultant for Linvatec, Vericel, MTF/Conmed, Smith & Nephew, DePuy, Moximed, and Zimmer; has received educational support from MTF/Conmed and Smith & Nephew; serves on the advisory panel for Vericel, MTF/Conmed, Histogenics, and Moximed; and has received hospitality payments from Wright Medical. B.C.F. receives a stipend for serving as an associate editor for The American Journal of Sports Medicine, has received hospitality payments from Smith & Nephew and consulting fees from New York R&D Center for Translational Medicine and Therapeutics, and is cofounder of Miach Orthopaedics. C.C.K. has received research support from DJO; educational support from CDC Medical, DePuy, and Smith & Nephew; consulting fees from Smith & Nephew and Zimmer Biomet; and nonconsulting payments from Arthrex. M.K. has received hospitality payments from Zimmer Biomet. T.S.L. has received educational support from Arthrex and Smith & Nephew and nonconsulting payments from Smith & Nephew. R.A.M. has received research support from Zimmer and educational support from Arthrex, CDC Medical, DonJoy, and Smith & Nephew. M.J.M. has received educational support from Apollo Surgical and Elite Orthopedics and consulting fees from Arthrex, Breg, Heron Therapeutics, Pacira, and Schwartz Biomedical. R.D.P. has received hospitality payments from the Musculoskeletal Transplant Foundation and Smith & Nephew and royalties from Zimmer Biomet. M.V.S. has received educational support from Arthrex and Elite Orthopedics, speaking fees from Arthrex and Elite Orthopedics, and consulting fees from Flexion Therapeutics and ISTO. C.W. has received consulting fees from Aastrom Biosciences, and his spouse owns stock in Pfizer and General Electric. R.W.W. receives royalties from Wolters Kluwer–Lippincott Williams & Wilkins. K.P.S. has received research support from DonJoy and Smith & Nephew; consulting fees from the National Football League, Cytori, and Mitek; and hospitality payments from DePuy and Biosense Webster. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.